(Q33762537)

29 July 2017

1 reference

title

Dendritic cell immunotherapy for cancer: application to low-grade lymphoma and multiple myeloma (English)

1 reference

29 July 2017

1 reference

1 reference

Hart DN

1

1 reference

29 July 2017

Hill GR

series ordinal

2

1 reference

29 July 2017

publication date

1 October 1999

1 reference

Immunology & Cell Biology

29 July 2017

published in

1 reference

29 July 2017

volume

77

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

451-459

1 reference

Strategies for immunoprophylaxis and immunotherapy of papillomaviruses

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Candidate vaccines for Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

The Labyrinthine Ways of Cancer Immunotherapy–T Cell, Tumor Cell Encounter: “How Do I Lose Thee? Let Me Count the Ways”

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Role of dendritic and follicular dendritic cells in HIV infection and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Expression of the RelB transcription factor correlates with the activation of human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

cDNA cloning of human DEC-205, a putative antigen-uptake receptor on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Optimisation of the conditions for generating human DC initiated antigen specific T lymphocyte lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Dendritic cells and cancer: progress toward a new cellular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Synovial fluid transforming growth factor beta inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Antitumor vaccination effect of dendritic cells can be augmented by locally utilizing Th1-type cytokines from OK432-reactive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Myeloma: new aspects of biology, prognosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Broadened clinical utility of gene gun-mediated, granulocyte-macrophage colony-stimulating factor cDNA-based tumor cell vaccines as demonstrated with a mouse myeloma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1999.00859.X

10.1046/J.1440-1711.1999.00859.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference